Clinical Trials List
Protocol NumberRAIN-3202
2023-07-01 - 2026-07-01
Phase II
Terminated1
-
Trial Applicant
Clinipace Taiwan Co., Ltd
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- TSUNG-HAO LIU Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
ˊ76 participants